Marked radiographic response of a HER-2-overexpressing biliary cancer to trastuzumab

Trastuzumab is a monoclonal antibody targeting HER-2. HER-2 overexpression has been described in gallbladder cancer and in cholangiocarcinoma. This report describes the first case of a patient with HER-2 overexpressing metastatic gallbladder adenocarcinoma and responding radiographically and biochem...

Descripción completa

Detalles Bibliográficos
Autor principal: Sorscher, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864990/
https://www.ncbi.nlm.nih.gov/pubmed/24376362
http://dx.doi.org/10.2147/CMAR.S55091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864990/
https://www.ncbi.nlm.nih.gov/pubmed/24376362
http://dx.doi.org/10.2147/CMAR.S55091

Ejemplares similares